EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting ecto‐5′‐nucleotidase (CD73) and cAMP alleviates carotid body hyperactivity and reduces blood pressure in chronically hypoxic rats

Demitris Nathanael iD, Andrew M Coney, Dhaifallah Alotaibi, Prem Kumar iD, Andrew P Holmes iD

The Journal of Physiology · 2026

DOI: 10.1113/jp289539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, 2026. Verfasst von Demitris Nathanael und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Infection, Inflammation and Immunology, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: 5'-Nucleotidase, Carotid Body, Hypoxia, Cyclic AMP. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education - Kingdom of Saudi Arabia, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hypoxia (CH) is a key feature of chronic obstructive pulmonary disease (COPD), and carotid body hyperactivity is a major contributor to the cardiovascular pathology seen in these patients. CD73, an ecto‐5′‐nucleotidase that converts AMP to adenosine, is functionally important in the healthy carotid body. However it is unknown if CD73 contributes to carotid body hyperactivity associated with CH. The current work investigated whether selective targeting of CD73 could attenuate carotid body hyperactivity and ameliorate cardiovascular function in CH animals. CH rats (F i O 2 of 12% for 10 days) exhibited basal carotid body chemoafferent hyperactivity, augmented hypoxic sensitivity and increased minute ventilation. Immunohistochemical analysis demonstrated that CH increased the number of tyrosine hydroxylase positive (TH + ) type I cells containing CD73 (CD73 + TH + ) within the carotid body. Pharmacological inhibition of CD73 using α, β‐methylene ADP (AOPCP) abolished CH‐induced basal chemoafferent hyperactivity and normalised the heightened hypoxic sensitivity ex vivo . These effects were largely mimicked by the transmembrane adenylyl cyclase (tmAC) inhibitor SQ22536. In vivo administration of AOPCP to CH animals caused a dose‐dependent decrease in arterial blood pressure, an effect that was attenuated following carotid sinus nerve section (CSNX). Therefore this research identifies CD73 and tmAC as important determinants of carotid body hyperactivity associated with CH. Effective targeting of CD73 alleviates carotid body hyperactivity, leading to a decrease in blood pressure, without abolishing reflex responses to hypoxia. These findings should be a first step towards the development of selective CD73/tmAC targeted therapies in the carotid body to safely improve cardiovascular outcomes in CH patients. image Key points Chronic hypoxia (CH), a key feature of chronic obstructive pulmonary disease, causes carotid body hyperactivity and cardiovascular pathology. The current work evaluated whether ecto‐5′‐nucleotidase (CD73) is important in promoting carotid body hyperactivity in CH animals. CH increases the proportion of type I cells containing CD73 (CD73 + TH + ) in the carotid body. Pharmacological targeting of CD73 and transmembrane adenylyl cyclases (tmAC) abolishes basal carotid body chemoafferent hyperactivity in CH and normalises the exaggerated responses to acute hypoxia ex vivo . In vivo inhibition of CD73 induces a dose‐dependent decrease in arterial blood pressure in normoxia, which is attenuated following carotid sinus nerve section. However AOPCP does not abolish cardiovascular‐respiratory responses to severe hypoxia. CD73 and tmAC are important in promoting carotid body hyperactivity in CH. Selective targeting of CD73 and cAMP signalling may safely reduce carotid body hyperactivity and thus improve cardiovascular outcomes in chronically hypoxic patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

5'-NucleotidaseCarotid BodyHypoxiaCyclic AMPBlood PressureAnimalsMaleRatsRats, Sprague-DawleyDiphosphatesAdenosine DiphosphateGPI-Linked Proteins

Stichwörter der Autor:innen

CD73blood pressurecAMPcarotid bodychronic hypoxia

Substanzen

5'-NucleotidaseCyclic AMPNt5e protein, ratDiphosphatesalpha,beta-methyleneadenosine 5'-diphosphateAdenosine DiphosphateGPI-Linked Proteins

Autor:innen und Institutionen

  • Department of Biomedical Sciences, School of Infection, Inflammation and Immunology, University of Birmingham, Birmingham, UK.
  • Department of Respiratory Therapy, College of Applied Medical Sciences, University of Bisha, Bisha, Kingdom of Saudi Arabia.
  • Department of Cardiovascular Sciences, School of Medical Sciences, University of Birmingham, Birmingham, UK.

ORCID-Profile: Demitris Nathanael, Prem Kumar, Andrew P Holmes

Förderung

  • Ministry of Education - Kingdom of Saudi Arabia
  • British Heart Foundation

Zitieren

APA

Nathanael, D., Coney, A. M., Alotaibi, D., Kumar, P., & Holmes, A. P. (2026). Targeting ecto‐5′‐nucleotidase (CD73) and cAMP alleviates carotid body hyperactivity and reduces blood pressure in chronically hypoxic rats. The Journal of Physiology. https://doi.org/10.1113/jp289539

Vancouver

Nathanael D, Coney AM, Alotaibi D, Kumar P, Holmes AP. Targeting ecto‐5′‐nucleotidase (CD73) and cAMP alleviates carotid body hyperactivity and reduces blood pressure in chronically hypoxic rats. The Journal of Physiology. 2026. doi:10.1113/jp289539

BibTeX
@article{Nathanael2026,
  author = {Nathanael, Demitris and Coney, Andrew M and Alotaibi, Dhaifallah and Kumar, Prem and Holmes, Andrew P},
  title = {Targeting ecto‐5′‐nucleotidase (CD73) and cAMP alleviates carotid body hyperactivity and reduces blood pressure in chronically hypoxic rats},
  journal = {The Journal of Physiology},
  year = {2026},
  doi = {10.1113/jp289539}
}
Kostenlos starten →